Fig. 1From: Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancerThe Receiver operating characteristic (ROC) curve of the nomogram for predictability of total pCR in HER2 breast cancer patientsBack to article page